Urs Christen

institute of general pharmacology and toxicology

H指数:41

被引数:8,087

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Molecular mimicry revisited: novel perspectives on autoimmune disease initiation and progression

分子模拟再探：自身免疫病起始与进展的新视角

Frontiers in Immunology

IF5.9

2026-09-230

OAAI

Sex-specific differences of amlexanox in a mouse model for atherosclerosis and MASLD

Molecular Metabolism

IF6.6

2026-07-210

OAAI

Restoring Balance in Autoimmune Hepatitis

恢复自身免疫性肝炎的平衡

Cellular and Molecular Gastroenterology and Hepatology

IF7.4

2026-04-280

OAAI

Corrigendum to “Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney” [Matrix Biology 68–69 (2018) 293–317]

勘误：“Biglycan，一种新型触发Th1和Th17细胞招募进入肾脏的因子”[细胞外基质生物学 68–69 (2018) 293–317]

Matrix Biology

IF4.8

2026-04-140

PRE

Inhibition of pyrimidine de novo synthesis fosters Treg cells and reduces diabetes development in models of Type 1 Diabetes

抑制嘧啶从头合成促进Treg细胞并减少1型糖尿病模型中糖尿病的发生

Molecular Metabolism

IF6.6

2025-07-220

OAAI

The XCL1/XCR1 axis is upregulated in type 1 diabetes and aggravates its pathogenesis

XCL1/XCR1轴在1型糖尿病中上调，并加剧其病理发生。

JCI INSIGHT

IF6.1

2025-02-270

Blockade of neutrophil extracellular trap components ameliorates cholestatic liver disease in Mdr2 (Abcb4) knockout mice

阻断中性粒细胞胞外诱捕成分可改善Mdr2 (Abcb4) 基因敲除小鼠的胆汁淤积性肝病

JOURNAL OF AUTOIMMUNITY

IF7

2024-06-012

Gene-expression profiling of laser-dissected islets and studies in deficient mice reveal chemokines as differential driving force of type 1 diabetes

JOURNAL OF AUTOIMMUNITY

IF7

2024-02-010

PRE

Gut dysbiosis promotes islet-autoimmunity by increasing T-cell attraction in islets via CXCL10 chemokine

JOURNAL OF AUTOIMMUNITY

IF7

2023-11-012

PRE

Distinct immune surveillance in primary biliary cholangitis and primary sclerosing cholangitis is linked with discrete cholangiocarcinoma risk

HEPATOLOGY COMMUNICATIONS

IF4.6

2023-09-012

OAAI

Combination treatment of a novel CXCR3 antagonist ACT-777991 with an anti-CD3 antibody synergistically increases persistent remission in experimental models of type 1 diabetes

CLINICAL AND EXPERIMENTAL IMMUNOLOGY

IF3.8

2023-07-173

OAAI

Analysis of 16 studies in nine rodent models does not support the hypothesis that diabetic polyuria is a main reason of urinary bladder enlargement

FRONTIERS IN PHYSIOLOGY

IF3.4

2022-08-086

OAAI

Animal Models for Autoimmune Hepatitis: Are Current Models Good Enough?

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-07-124

OAAI

Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2020-10-1928

OAAI

Interleukin-22 in acute-on-chronic liver failure: A matter of ineffective levels, receptor dysregulation or defective signalling?

JOURNAL OF HEPATOLOGY

IF33

2020-10-017

OAAI

Ubiquitous antigen-specific T regulatory type 1 cells variably suppress hepatic and extrahepatic autoimmunity

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2020-03-0331

Breakdown of tolerance in autoimmune hepatitis: This time toxin beats virus

IMMUNOLOGY LETTERS

IF2.8

2020-02-010

PREAI

The Many Roles of Cell Adhesion Molecules in Hepatic Fibrosis

CELLS

IF5.2

2019-11-2466

OAAI

Effects of adenovirus-induced hepatocyte damage on chronic bile duct inflammation in a sclerosing cholangitis mouse model

LIVER INTERNATIONAL

IF5.2

2019-07-104

PREAI

Establishment of a new animal model for the acute-on-chronic liver failure

JOURNAL OF HEPATOLOGY

IF33

2019-04-012

PREAI

Urs Christen

个人简介

教育背景

工作经历

荣誉奖项

研究方向